How a biotech startup is using dogs and AI to rewrite the rules of cancer screening

Man’s best friend may become cancer’s worst enemy.

Kyoto team finds way to detect early pancreatic cancer with AI

KYOTO--Researchers here say they developed a highly accurate method to detect early signs of pancreatic cancer using ...
STAT

Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story

At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to hear Charles Swanton of the Francis Crick Institute in London share results ...

ClearNote Health Grabs $52 Million for Early Pancreatic Cancer Detection

The San Diego company says its blood test can detect pancreatic cancer when curative surgery may still be an option.

ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection

Proceeds will support continued commercial expansion, operational scale-up, clinical study execution, and product development * Clinical oncology ...
Ventureburn

ClearNote Health Secures $52 Million to Scale Early Cancer Detection

ClearNote Health secures $52 million to scale early cancer detection and expand global clinical and commercial operations.
MarketBeat on MSN

GRAIL's Galleri test cuts stage 4 cancer diagnoses in study despite missed endpoint

Key Points Interested in GRAIL, Inc.? Here are five stocks we like better. GRAIL said its Galleri blood test showed it can ...